Sana Biotechnology, Inc. (CIK: 0001770121) EDGAR, Information, Filings... CompaniesBIO.Com

Sana Biotechnology, Inc.

Mailing address
188 EAST BLAINE STREET, SUIT 400, SEATTLE, Delaware, 98102
Phone
(206) 701-7914
State location
Washington
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Sana Biotechnology, Inc. (CIK: 0001770121) is an American company incorporated in the state of Washington. Head office is located at 188 EAST BLAINE STREET, SUIT 400, SEATTLE, Washington, 98102. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Sana Biotechnology, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
WILLIAMS DOUGLAS E	0001184847	Apr-10-2023	officer: EVP & President, R&D
Cassidy Bernard J	0001398322	Sep-12-2022	officer: EVP & General Counsel
ARCH Venture Partners IX, L.P.	0001723173	Feb-08-2021	10 percent owner
Wilderotter Mary Agnes	0001180610	Feb-03-2021	director
CRANDELL KEITH	0001219039	Feb-03-2021	10 percent owner
NELSEN ROBERT	0001219042	Feb-03-2021	director
BYBEE CLINTON	0001219043	Feb-03-2021	10 percent owner
AFEYAN NOUBAR	0001222012	Feb-03-2021	10 percent owner
GILLIS STEVEN	0001229592	Feb-03-2021	10 percent owner
Yang Patrick Y	0001309988	Feb-03-2021	director
Mulligan Richard	0001376247	Feb-03-2021	director, officer: Head of SanaX
Flagship Pioneering Inc.	0001400240	Feb-03-2021	10 percent owner
Bishop Hans Edgar	0001480212	Feb-03-2021	director
Cole Douglas G.	0001486373	Feb-03-2021	director
Burow Kristina	0001569248	Feb-03-2021	10 percent owner
Bilenker Joshua H.	0001612312	Feb-03-2021	director
AGARWAL SUNIL	0001616640	Feb-03-2021	officer: See Remarks
Harr Steve	0001627387	Feb-03-2021	director, officer: President & CEO
Flagship Ventures Fund V, L.P.	0001627639	Feb-03-2021	10 percent owner
ARCH Venture Fund IX, L.P.	0001666306	Feb-03-2021	10 percent owner
ARCH Venture Fund IX Overage, L.P.	0001666307	Feb-03-2021	10 percent owner
Flagship Pioneering Fund VI, L.P.	0001716926	Feb-03-2021	10 percent owner
ARCH Venture Partners IX Overage, L.P.	0001723172	Feb-03-2021	10 percent owner
ARCH Venture Partners IX, LLC	0001723174	Feb-03-2021	10 percent owner
Flagship Ventures Fund V General Partner LLC	0001724575	Feb-03-2021	10 percent owner
Flagship V VentureLabs Rx Fund, L.P.	0001724939	Feb-03-2021	10 percent owner
Flagship Pioneering Fund VI General Partner LLC	0001724957	Feb-03-2021	10 percent owner
Flagship VentureLabs V LLC	0001724959	Feb-03-2021	10 percent owner
ARCH Venture Fund X, L.P.	0001757011	Feb-03-2021	10 percent owner
ARCH Venture Fund X Overage, L.P.	0001757017	Feb-03-2021	10 percent owner
REICIN ALISE	0001757533	Feb-03-2021	director
von Maltzahn Geoffrey	0001768286	Feb-03-2021	director
ARCH Venture Partners X Overage, L.P.	0001768905	Feb-03-2021	10 percent owner
Flagship VentureLabs V Manager LLC	0001768987	Feb-03-2021	10 percent owner
ARCH Venture Partners X, LLC	0001769012	Feb-03-2021	10 percent owner
ARCH Venture Partners X, L.P.	0001782583	Feb-03-2021	10 percent owner
Hardy Nathan	0001830053	Feb-03-2021	officer: SVP, Chief Financial Officer
MacDonald James J.	0001830054	Feb-03-2021	officer: See Remarks
Hordo Christian	0001830070	Feb-03-2021	officer: SVP, Chief Business Officer
Seitz Michelle	0001836301	Feb-03-2021	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Sana Biotechnology, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001480212-26-000002 ( Act) Size: 0 KB	Jan-06-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001568605-26-000002 ( Act) Size: 0 KB	Jan-06-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001568605-25-000007 ( Act) Size: 0 KB	Dec-16-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001568605-25-000005 ( Act) Size: 0 KB	Dec-05-2025
SCHEDULE 13G/A	Document	Acc-no: 0001012975-25-000773 (34 Act) Size: KB	Nov-14-2025	005-92124 251487026
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001193125-25-269569 (34 Act) Size: KB	Nov-06-2025	001-39941 251458500
8-K	Document	Current report filing Acc-no: 0001193125-25-269522 (34 Act) Size: KB	Nov-06-2025	001-39941 251458367
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001480212-25-000006 ( Act) Size: 0 KB	Oct-07-2025
UPLOAD	Document	Acc-no: 0000000000-25-009796 ( Act) Size: KB	Sep-10-2025	001-39941
8-K	Document	Current report filing Acc-no: 0001193125-25-196414 (34 Act) Size: KB	Sep-05-2025	001-39941 251294925
8-K	Document	Current report filing Acc-no: 0001193125-25-192766 (34 Act) Size: KB	Aug-29-2025	001-39941 251280973
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001193125-25-179835 ( Act) Size: KB	Aug-13-2025
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001770121-25-000010 (34 Act) Size: KB	Aug-11-2025	001-39941 251202095
8-K	Document	Current report filing Acc-no: 0001770121-25-000009 (34 Act) Size: KB	Aug-11-2025	001-39941 251202061
8-K	Document	Current report filing Acc-no: 0001193125-25-175571 (34 Act) Size: KB	Aug-07-2025	001-39941 251195288
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-25-175493 (33 Act) Size: KB	Aug-07-2025	333-277584 251194815
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-25-174567 (33 Act) Size: KB	Aug-06-2025	333-277584 251190632
8-K	Document	Current report filing Acc-no: 0001193125-25-174506 (34 Act) Size: KB	Aug-06-2025	001-39941 251190157
UPLOAD	Document	Acc-no: 0000000000-25-007978 ( Act) Size: KB	Jul-30-2025	001-39941
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-25-005349 ( Act) Size: 0 KB	Jul-08-2025

Recent 20 filings. View all Sana Biotechnology, Inc. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Sana Biotechnology, Inc. overview
Sana Biotechnology, Inc. job
Sana Biotechnology, Inc. stock
Sana Biotechnology, Inc. ownership
Sana Biotechnology, Inc. CEO
Sana Biotechnology, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.